CHS Inc. (CHSCP) Stock Competitors & Peer Comparison
See (CHSCP) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHSCP | $27.51 | +0.00% | 337.6M | N/A | N/A | +7.35% |
| ADM | $75.10 | -1.83% | 36.2B | 33.53 | $2.24 | +2.74% |
| BG | $112.58 | -3.07% | 21.8B | 29.63 | $3.80 | +2.50% |
| TSN | $55.46 | -1.32% | 19.7B | 43.67 | $1.27 | +3.66% |
| SFD | $24.94 | -0.36% | 9.8B | 9.70 | $2.57 | +4.51% |
| AGRO | $9.24 | -4.15% | 5.2B | 462.00 | $0.02 | +3.20% |
| CALM | $77.73 | -0.73% | 3.7B | 5.41 | $14.37 | +6.19% |
| IBA | $53.00 | -1.82% | 2.6B | 7.77 | $6.82 | +1.84% |
| DOLE | $14.00 | -0.43% | 1.3B | 15.05 | $0.93 | +2.43% |
| FDP | $27.44 | -1.15% | 1.3B | 18.92 | $1.45 | +4.37% |
Stock Comparison
CHSCP vs ADM Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, ADM has a market cap of 36.2B. Regarding current trading prices, CHSCP is priced at $27.51, while ADM trades at $75.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas ADM's P/E ratio is 33.53. In terms of profitability, CHSCP's ROE is +0.05%, compared to ADM's ROE of +0.05%. Regarding short-term risk, CHSCP is less volatile compared to ADM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check ADM's competition here
CHSCP vs BG Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, BG has a market cap of 21.8B. Regarding current trading prices, CHSCP is priced at $27.51, while BG trades at $112.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas BG's P/E ratio is 29.63. In terms of profitability, CHSCP's ROE is +0.05%, compared to BG's ROE of +0.05%. Regarding short-term risk, CHSCP is less volatile compared to BG. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check BG's competition here
CHSCP vs TSN Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, TSN has a market cap of 19.7B. Regarding current trading prices, CHSCP is priced at $27.51, while TSN trades at $55.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas TSN's P/E ratio is 43.67. In terms of profitability, CHSCP's ROE is +0.05%, compared to TSN's ROE of +0.02%. Regarding short-term risk, CHSCP is less volatile compared to TSN. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check TSN's competition here
CHSCP vs SFD Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, SFD has a market cap of 9.8B. Regarding current trading prices, CHSCP is priced at $27.51, while SFD trades at $24.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas SFD's P/E ratio is 9.70. In terms of profitability, CHSCP's ROE is +0.05%, compared to SFD's ROE of +0.15%. Regarding short-term risk, CHSCP is less volatile compared to SFD. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check SFD's competition here
CHSCP vs AGRO Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, AGRO has a market cap of 5.2B. Regarding current trading prices, CHSCP is priced at $27.51, while AGRO trades at $9.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AGRO's P/E ratio is 462.00. In terms of profitability, CHSCP's ROE is +0.05%, compared to AGRO's ROE of +0.01%. Regarding short-term risk, CHSCP is less volatile compared to AGRO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AGRO's competition here
CHSCP vs CALM Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, CALM has a market cap of 3.7B. Regarding current trading prices, CHSCP is priced at $27.51, while CALM trades at $77.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas CALM's P/E ratio is 5.41. In terms of profitability, CHSCP's ROE is +0.05%, compared to CALM's ROE of +0.26%. Regarding short-term risk, CHSCP is less volatile compared to CALM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check CALM's competition here
CHSCP vs IBA Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, IBA has a market cap of 2.6B. Regarding current trading prices, CHSCP is priced at $27.51, while IBA trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas IBA's P/E ratio is 7.77. In terms of profitability, CHSCP's ROE is +0.05%, compared to IBA's ROE of +0.12%. Regarding short-term risk, CHSCP is less volatile compared to IBA. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check IBA's competition here
CHSCP vs DOLE Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, DOLE has a market cap of 1.3B. Regarding current trading prices, CHSCP is priced at $27.51, while DOLE trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas DOLE's P/E ratio is 15.05. In terms of profitability, CHSCP's ROE is +0.05%, compared to DOLE's ROE of +0.03%. Regarding short-term risk, CHSCP is less volatile compared to DOLE. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check DOLE's competition here
CHSCP vs FDP Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, FDP has a market cap of 1.3B. Regarding current trading prices, CHSCP is priced at $27.51, while FDP trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas FDP's P/E ratio is 18.92. In terms of profitability, CHSCP's ROE is +0.05%, compared to FDP's ROE of +0.03%. Regarding short-term risk, CHSCP is less volatile compared to FDP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check FDP's competition here
CHSCP vs VITL Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, VITL has a market cap of 446.1M. Regarding current trading prices, CHSCP is priced at $27.51, while VITL trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas VITL's P/E ratio is 10.01. In terms of profitability, CHSCP's ROE is +0.05%, compared to VITL's ROE of +0.14%. Regarding short-term risk, CHSCP is less volatile compared to VITL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check VITL's competition here
CHSCP vs LND Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, LND has a market cap of 355.6M. Regarding current trading prices, CHSCP is priced at $27.51, while LND trades at $3.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas LND's P/E ratio is -119.00. In terms of profitability, CHSCP's ROE is +0.05%, compared to LND's ROE of -0.02%. Regarding short-term risk, CHSCP is less volatile compared to LND. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check LND's competition here
CHSCP vs CHSCO Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, CHSCO has a market cap of 320.4M. Regarding current trading prices, CHSCP is priced at $27.51, while CHSCO trades at $26.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas CHSCO's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to CHSCO's ROE of +0.05%. Regarding short-term risk, CHSCP is less volatile compared to CHSCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check CHSCO's competition here
CHSCP vs CHSCL Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, CHSCL has a market cap of 312.9M. Regarding current trading prices, CHSCP is priced at $27.51, while CHSCL trades at $25.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas CHSCL's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to CHSCL's ROE of +0.05%. Regarding short-term risk, CHSCP is less volatile compared to CHSCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check CHSCL's competition here
CHSCP vs CHSCN Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, CHSCN has a market cap of 307.7M. Regarding current trading prices, CHSCP is priced at $27.51, while CHSCN trades at $25.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas CHSCN's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to CHSCN's ROE of +0.05%. Regarding short-term risk, CHSCP is less volatile compared to CHSCN. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check CHSCN's competition here
CHSCP vs CHSCM Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, CHSCM has a market cap of 303.7M. Regarding current trading prices, CHSCP is priced at $27.51, while CHSCM trades at $24.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas CHSCM's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to CHSCM's ROE of +0.05%. Regarding short-term risk, CHSCP is less volatile compared to CHSCM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check CHSCM's competition here
CHSCP vs ALCO Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, ALCO has a market cap of 299.2M. Regarding current trading prices, CHSCP is priced at $27.51, while ALCO trades at $40.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas ALCO's P/E ratio is -16.33. In terms of profitability, CHSCP's ROE is +0.05%, compared to ALCO's ROE of -0.18%. Regarding short-term risk, CHSCP is less volatile compared to ALCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check ALCO's competition here
CHSCP vs AFRIW Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, AFRIW has a market cap of 271M. Regarding current trading prices, CHSCP is priced at $27.51, while AFRIW trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AFRIW's P/E ratio is -30.43. In terms of profitability, CHSCP's ROE is +0.05%, compared to AFRIW's ROE of +2.87%. Regarding short-term risk, CHSCP is less volatile compared to AFRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AFRIW's competition here
CHSCP vs AFRI Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, AFRI has a market cap of 271M. Regarding current trading prices, CHSCP is priced at $27.51, while AFRI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AFRI's P/E ratio is -22.33. In terms of profitability, CHSCP's ROE is +0.05%, compared to AFRI's ROE of +2.87%. Regarding short-term risk, CHSCP is less volatile compared to AFRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AFRI's competition here
CHSCP vs LMNR Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, LMNR has a market cap of 237M. Regarding current trading prices, CHSCP is priced at $27.51, while LMNR trades at $13.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas LMNR's P/E ratio is -5.71. In terms of profitability, CHSCP's ROE is +0.05%, compared to LMNR's ROE of -0.25%. Regarding short-term risk, CHSCP is less volatile compared to LMNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check LMNR's competition here
CHSCP vs VFF Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, VFF has a market cap of 232.7M. Regarding current trading prices, CHSCP is priced at $27.51, while VFF trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas VFF's P/E ratio is 8.68. In terms of profitability, CHSCP's ROE is +0.05%, compared to VFF's ROE of +0.14%. Regarding short-term risk, CHSCP is less volatile compared to VFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check VFF's competition here
CHSCP vs AGFS Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, AGFS has a market cap of 161.2M. Regarding current trading prices, CHSCP is priced at $27.51, while AGFS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AGFS's P/E ratio is -2.61. In terms of profitability, CHSCP's ROE is +0.05%, compared to AGFS's ROE of -0.12%. Regarding short-term risk, CHSCP is less volatile compared to AGFS. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AGFS's competition here
CHSCP vs AVX Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, AVX has a market cap of 41.6M. Regarding current trading prices, CHSCP is priced at $27.51, while AVX trades at $5.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AVX's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to AVX's ROE of -0.87%. Regarding short-term risk, CHSCP is less volatile compared to AVX. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AVX's competition here
CHSCP vs LOCL Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, LOCL has a market cap of 29.4M. Regarding current trading prices, CHSCP is priced at $27.51, while LOCL trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas LOCL's P/E ratio is -0.71. In terms of profitability, CHSCP's ROE is +0.05%, compared to LOCL's ROE of +0.44%. Regarding short-term risk, CHSCP is less volatile compared to LOCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check LOCL's competition here
CHSCP vs PME Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, PME has a market cap of 23.2M. Regarding current trading prices, CHSCP is priced at $27.51, while PME trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas PME's P/E ratio is 13.50. In terms of profitability, CHSCP's ROE is +0.05%, compared to PME's ROE of -0.03%. Regarding short-term risk, CHSCP is less volatile compared to PME. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check PME's competition here
CHSCP vs SDOT Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, SDOT has a market cap of 16.4M. Regarding current trading prices, CHSCP is priced at $27.51, while SDOT trades at $16.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas SDOT's P/E ratio is -0.01. In terms of profitability, CHSCP's ROE is +0.05%, compared to SDOT's ROE of +6.12%. Regarding short-term risk, CHSCP is less volatile compared to SDOT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check SDOT's competition here
CHSCP vs APPHW Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, APPHW has a market cap of 10.3M. Regarding current trading prices, CHSCP is priced at $27.51, while APPHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas APPHW's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to APPHW's ROE of -0.55%. Regarding short-term risk, CHSCP is less volatile compared to APPHW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check APPHW's competition here
CHSCP vs APPH Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, APPH has a market cap of 10.3M. Regarding current trading prices, CHSCP is priced at $27.51, while APPH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas APPH's P/E ratio is -0.14. In terms of profitability, CHSCP's ROE is +0.05%, compared to APPH's ROE of -0.55%. Regarding short-term risk, CHSCP is less volatile compared to APPH. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check APPH's competition here
CHSCP vs AQB Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, AQB has a market cap of 3.6M. Regarding current trading prices, CHSCP is priced at $27.51, while AQB trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AQB's P/E ratio is -0.95. In terms of profitability, CHSCP's ROE is +0.05%, compared to AQB's ROE of -3.68%. Regarding short-term risk, CHSCP is less volatile compared to AQB. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AQB's competition here
CHSCP vs KAL Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, KAL has a market cap of 2.1M. Regarding current trading prices, CHSCP is priced at $27.51, while KAL trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas KAL's P/E ratio is -0.01. In terms of profitability, CHSCP's ROE is +0.05%, compared to KAL's ROE of -0.19%. Regarding short-term risk, CHSCP is less volatile compared to KAL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check KAL's competition here
CHSCP vs KALWW Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, KALWW has a market cap of 2.1M. Regarding current trading prices, CHSCP is priced at $27.51, while KALWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas KALWW's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to KALWW's ROE of -0.19%. Regarding short-term risk, CHSCP is less volatile compared to KALWW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check KALWW's competition here
CHSCP vs AGRI Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, AGRI has a market cap of 1.9M. Regarding current trading prices, CHSCP is priced at $27.51, while AGRI trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AGRI's P/E ratio is 0.00. In terms of profitability, CHSCP's ROE is +0.05%, compared to AGRI's ROE of -0.92%. Regarding short-term risk, CHSCP is less volatile compared to AGRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AGRI's competition here
CHSCP vs EDBLW Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, EDBLW has a market cap of 1.8M. Regarding current trading prices, CHSCP is priced at $27.51, while EDBLW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas EDBLW's P/E ratio is -0.03. In terms of profitability, CHSCP's ROE is +0.05%, compared to EDBLW's ROE of -1.39%. Regarding short-term risk, CHSCP is less volatile compared to EDBLW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check EDBLW's competition here
CHSCP vs AGRIW Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, AGRIW has a market cap of 66.2K. Regarding current trading prices, CHSCP is priced at $27.51, while AGRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AGRIW's P/E ratio is -0.01. In terms of profitability, CHSCP's ROE is +0.05%, compared to AGRIW's ROE of -0.87%. Regarding short-term risk, CHSCP is less volatile compared to AGRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AGRIW's competition here
CHSCP vs EDBL Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, EDBL has a market cap of 62.7K. Regarding current trading prices, CHSCP is priced at $27.51, while EDBL trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas EDBL's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to EDBL's ROE of -1.39%. Regarding short-term risk, CHSCP is less volatile compared to EDBL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check EDBL's competition here
CHSCP vs AAGRW Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, AAGRW has a market cap of 57.9K. Regarding current trading prices, CHSCP is priced at $27.51, while AAGRW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AAGRW's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to AAGRW's ROE of +3.27%. Regarding short-term risk, CHSCP is less volatile compared to AAGRW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AAGRW's competition here
CHSCP vs DTCK Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, DTCK has a market cap of 3.1K. Regarding current trading prices, CHSCP is priced at $27.51, while DTCK trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas DTCK's P/E ratio is -0.27. In terms of profitability, CHSCP's ROE is +0.05%, compared to DTCK's ROE of -1.28%. Regarding short-term risk, CHSCP is less volatile compared to DTCK. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check DTCK's competition here
CHSCP vs LOCL-WT Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, LOCL-WT has a market cap of 0. Regarding current trading prices, CHSCP is priced at $27.51, while LOCL-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas LOCL-WT's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to LOCL-WT's ROE of +0.44%. Regarding short-term risk, CHSCP is less volatile compared to LOCL-WT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check LOCL-WT's competition here
CHSCP vs OME Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, OME has a market cap of 0. Regarding current trading prices, CHSCP is priced at $27.51, while OME trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas OME's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to OME's ROE of +0.10%. Regarding short-term risk, CHSCP is more volatile compared to OME. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCP.Check OME's competition here
CHSCP vs TSNU Comparison June 2026
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 337.6M. In comparison, TSNU has a market cap of 0. Regarding current trading prices, CHSCP is priced at $27.51, while TSNU trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas TSNU's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to TSNU's ROE of +0.02%. Regarding short-term risk, CHSCP is less volatile compared to TSNU. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check TSNU's competition here